India’s Cheaper Weight-Loss Drug Era Could Change the Fight Against Diabetes and Obesity
By contrast, newly launched generic versions are reportedly being introduced at roughly ₹1,290 to ₹4,200 per month, which could make them 65 to 90 percent cheaper than earlier options.